Flow analysis of individual blood extracellular vesicles in acute coronary syndrome

Murad Vagida, Anush Arakelyan, Anna Lebedeva, Jean-Charles B. Grivel, Alexander Shpektor, Elena Vasilieva, Leonid Margolis

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A diverse population of small extracellular vesicles (EVs) that are released by various cells has been characterized predominantly in bulk, a procedure whereby the individual characteristics of EVs are lost. Here, we used a new nanotechnology-based flow cytometric analysis to characterize the antigenic composition of individual EVs in patients with acute coronary syndrome (ACS). Plasma EVs were captured with 15-nm magnetic nanoparticles coupled to antibodies against CD31 (predominantly an endothelial marker), CD41a (a marker for platelets), and CD63 or MHC class I (common EV markers). The total amounts of EVs were higher in the ACS patients than in the controls, predominantly due to the contribution of patients with acute myocardial infarction. For all captured fractions, the differences in the EV amounts were restricted to CD41a+ EVs. The increase in the numbers of EVs in the ACS patients, predominantly of platelet origin, probably reflects platelet activation and may indicate disease progression.

Original languageEnglish
Pages (from-to)165-173
Number of pages9
JournalPlatelets
Volume28
Issue number2
DOIs
Publication statusPublished - 17 Feb 2017

Fingerprint

Acute Coronary Syndrome
Blood Platelets
Extracellular Vesicles
Nanotechnology
Platelet Activation
Nanoparticles
Disease Progression
Myocardial Infarction
Antibodies

Keywords

  • Acute coronary syndrome
  • acute myocardial infarction
  • extracellular vesicles
  • flowcytometry
  • platelets

ASJC Scopus subject areas

  • Hematology

Cite this

Vagida, M., Arakelyan, A., Lebedeva, A., Grivel, J-C. B., Shpektor, A., Vasilieva, E., & Margolis, L. (2017). Flow analysis of individual blood extracellular vesicles in acute coronary syndrome. Platelets, 28(2), 165-173. https://doi.org/10.1080/09537104.2016.1212002

Flow analysis of individual blood extracellular vesicles in acute coronary syndrome. / Vagida, Murad; Arakelyan, Anush; Lebedeva, Anna; Grivel, Jean-Charles B.; Shpektor, Alexander; Vasilieva, Elena; Margolis, Leonid.

In: Platelets, Vol. 28, No. 2, 17.02.2017, p. 165-173.

Research output: Contribution to journalArticle

Vagida, M, Arakelyan, A, Lebedeva, A, Grivel, J-CB, Shpektor, A, Vasilieva, E & Margolis, L 2017, 'Flow analysis of individual blood extracellular vesicles in acute coronary syndrome', Platelets, vol. 28, no. 2, pp. 165-173. https://doi.org/10.1080/09537104.2016.1212002
Vagida, Murad ; Arakelyan, Anush ; Lebedeva, Anna ; Grivel, Jean-Charles B. ; Shpektor, Alexander ; Vasilieva, Elena ; Margolis, Leonid. / Flow analysis of individual blood extracellular vesicles in acute coronary syndrome. In: Platelets. 2017 ; Vol. 28, No. 2. pp. 165-173.
@article{855b6d37526e4d8cade635a4e0dff584,
title = "Flow analysis of individual blood extracellular vesicles in acute coronary syndrome",
abstract = "A diverse population of small extracellular vesicles (EVs) that are released by various cells has been characterized predominantly in bulk, a procedure whereby the individual characteristics of EVs are lost. Here, we used a new nanotechnology-based flow cytometric analysis to characterize the antigenic composition of individual EVs in patients with acute coronary syndrome (ACS). Plasma EVs were captured with 15-nm magnetic nanoparticles coupled to antibodies against CD31 (predominantly an endothelial marker), CD41a (a marker for platelets), and CD63 or MHC class I (common EV markers). The total amounts of EVs were higher in the ACS patients than in the controls, predominantly due to the contribution of patients with acute myocardial infarction. For all captured fractions, the differences in the EV amounts were restricted to CD41a+ EVs. The increase in the numbers of EVs in the ACS patients, predominantly of platelet origin, probably reflects platelet activation and may indicate disease progression.",
keywords = "Acute coronary syndrome, acute myocardial infarction, extracellular vesicles, flowcytometry, platelets",
author = "Murad Vagida and Anush Arakelyan and Anna Lebedeva and Grivel, {Jean-Charles B.} and Alexander Shpektor and Elena Vasilieva and Leonid Margolis",
year = "2017",
month = "2",
day = "17",
doi = "10.1080/09537104.2016.1212002",
language = "English",
volume = "28",
pages = "165--173",
journal = "Platelets",
issn = "0953-7104",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Flow analysis of individual blood extracellular vesicles in acute coronary syndrome

AU - Vagida, Murad

AU - Arakelyan, Anush

AU - Lebedeva, Anna

AU - Grivel, Jean-Charles B.

AU - Shpektor, Alexander

AU - Vasilieva, Elena

AU - Margolis, Leonid

PY - 2017/2/17

Y1 - 2017/2/17

N2 - A diverse population of small extracellular vesicles (EVs) that are released by various cells has been characterized predominantly in bulk, a procedure whereby the individual characteristics of EVs are lost. Here, we used a new nanotechnology-based flow cytometric analysis to characterize the antigenic composition of individual EVs in patients with acute coronary syndrome (ACS). Plasma EVs were captured with 15-nm magnetic nanoparticles coupled to antibodies against CD31 (predominantly an endothelial marker), CD41a (a marker for platelets), and CD63 or MHC class I (common EV markers). The total amounts of EVs were higher in the ACS patients than in the controls, predominantly due to the contribution of patients with acute myocardial infarction. For all captured fractions, the differences in the EV amounts were restricted to CD41a+ EVs. The increase in the numbers of EVs in the ACS patients, predominantly of platelet origin, probably reflects platelet activation and may indicate disease progression.

AB - A diverse population of small extracellular vesicles (EVs) that are released by various cells has been characterized predominantly in bulk, a procedure whereby the individual characteristics of EVs are lost. Here, we used a new nanotechnology-based flow cytometric analysis to characterize the antigenic composition of individual EVs in patients with acute coronary syndrome (ACS). Plasma EVs were captured with 15-nm magnetic nanoparticles coupled to antibodies against CD31 (predominantly an endothelial marker), CD41a (a marker for platelets), and CD63 or MHC class I (common EV markers). The total amounts of EVs were higher in the ACS patients than in the controls, predominantly due to the contribution of patients with acute myocardial infarction. For all captured fractions, the differences in the EV amounts were restricted to CD41a+ EVs. The increase in the numbers of EVs in the ACS patients, predominantly of platelet origin, probably reflects platelet activation and may indicate disease progression.

KW - Acute coronary syndrome

KW - acute myocardial infarction

KW - extracellular vesicles

KW - flowcytometry

KW - platelets

UR - http://www.scopus.com/inward/record.url?scp=84991031857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991031857&partnerID=8YFLogxK

U2 - 10.1080/09537104.2016.1212002

DO - 10.1080/09537104.2016.1212002

M3 - Article

C2 - 27595614

AN - SCOPUS:84991031857

VL - 28

SP - 165

EP - 173

JO - Platelets

JF - Platelets

SN - 0953-7104

IS - 2

ER -